01 1HLB Pep Co., Ltd.
01 1HLB Pep Co., Ltd.
01 1Arginine vasopressin acetate
01 1South Korea
Registrant Name : HLB Pep Co., Ltd.
Registration Date : 2025-11-27
Registration Number : 20251127-210-J-2068
Manufacturer Name : HLB Pep Co., Ltd.
Manufacturer Address : 773 Jeongjungyeon-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do
12
PharmaCompass offers a list of Arginine Vasopressin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Arginine Vasopressin manufacturer or Arginine Vasopressin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Arginine Vasopressin manufacturer or Arginine Vasopressin supplier.
A Argipressinum manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Argipressinum, including repackagers and relabelers. The FDA regulates Argipressinum manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Argipressinum API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Argipressinum manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Argipressinum supplier is an individual or a company that provides Argipressinum active pharmaceutical ingredient (API) or Argipressinum finished formulations upon request. The Argipressinum suppliers may include Argipressinum API manufacturers, exporters, distributors and traders.
click here to find a list of Argipressinum suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Argipressinum Drug Master File in Korea (Argipressinum KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Argipressinum. The MFDS reviews the Argipressinum KDMF as part of the drug registration process and uses the information provided in the Argipressinum KDMF to evaluate the safety and efficacy of the drug.
After submitting a Argipressinum KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Argipressinum API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Argipressinum suppliers with KDMF on PharmaCompass.
